[1]赵海君,张皙卉,卢　静,等.高纯度人绝经期促性腺激素对不同年龄卵巢储备功能正常不孕患者体外受精-胚胎移植结局的影响[J].新乡医学院学报,2022,39(6):544-547.[doi:10.7683/xxyxyxb.2022.06.009]
　ZHAO Haijun,ZHANG Xihui,LU Jing,et al.Effect of highly purified human menopausal gonadotrophin on outcomes of in vitro fertilization-embryo transfer in infertile patients with normal ovarian reserve at different ages[J].Journal of Xinxiang Medical University,2022,39(6):544-547.[doi:10.7683/xxyxyxb.2022.06.009]
点击复制

高纯度人绝经期促性腺激素对不同年龄卵巢储备功能正常不孕患者体外受精-胚胎移植结局的影响
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
39
期数:
2022年6
页码:
544-547
栏目:
临床研究
出版日期:
2022-06-05

文章信息/Info

Title:
Effect of highly purified human menopausal gonadotrophin on outcomes of in vitro fertilization-embryo transfer in infertile patients with normal ovarian reserve at different ages
作者:
赵海君1; 张皙卉1; 卢　静1; 张一娇1; 王玉红1; 陈　静1; 景　丽1; 常月婷2; 常文亮1
（1.邯郸市中心医院生殖医学科，河北　邯郸　056000；2.石家庄市第四医院妇二科，河北　石家庄　050000）
Author(s):
ZHAO Haijun1; ZHANG Xihui1; LU Jing1; ZHANG Yijiao1; WANG Yuhong1; CHEN Jing1; JING Li1; CHANG Yueting2; CHANG Wenliang1
(1.Department of Reproductive Medicine，Handan Central Hospital,Handan 056000,Hebei Province,China;2.The Second Department of Gynecology,the Fourth Hospital of Shijiazhuang,Shijiazhuang 050000,Hebei Province,China)
关键词:
高纯度人绝经期促性腺激素; 不孕症; 体外受精; 胚胎移植
Keywords:
highly purified human menopausal gonadotrophin; infertility; in vitro fertilization; embryo transfer
分类号:
R715.2
DOI:
10.7683/xxyxyxb.2022.06.009
文献标志码:
A
摘要:
目的　探讨高纯度人绝经期促性腺激素（HP-HMG）对不同年龄卵巢储备功能正常不孕患者体外受精-胚胎移植（IVF-ET）结局的影响。方法　回顾性分析2015年6月至2019年12月在邯郸市中心医院采用HP-HMG促排卵行IVF-ET助孕的127例患者的临床资料，根据年龄将患者分为低龄组（<35岁，n=63）和高龄组（≥35岁，n=64）。比较2组患者促排卵指标和实验室及移植后临床结局指标。结果　2组患者的促性腺激素（Gn）用量、人绒毛膜促性腺激素（HCG）注射日雌二醇水平、HCG注射日黄体生成素水平、HCG注射孕酮水平、第Ⅱ次减数分裂中期卵数、可利用胚胎数、临床妊娠率、胚胎种植率及流产率比较差异均无统计学意义（P>0.05）。高龄组患者Gn使用时间和获卵数显著少于低龄组，优质胚胎率显著高于低龄组（P<0.05）。 结论　HP-HMG促排卵有助于提高高龄卵巢储备功能正常不孕患者优质胚胎率，改善IVF-ET妊娠结局。
Abstract:
Objective　To investigate the effect of highly purified human menopausal gonadotropin (HP-HMG) on outcomes of in vitro fertilization-embryo transfer(IVF-ET) of infertile patients with normal ovarian reserve at different ages.Methods　The clinical data of 127 patients who received HP-HMG ovulation induction for IVF-ET in Handan Central Hospital from June 2015 to December 2019 were retrospectively analyzed.The patients were divided into younger group(<35 years old,n=63) and older group(≥35 years old,n=64) according to the age.The ovulation induction indicators,laboratory indexes and post transplant clinical outcomes of patients were analyzed between the two groups.Results　There was no significant difference in the gonadotrophin(Gn) dosage,estrogen level on the human chorionic gonadotropin (HCG) injection day,luteinizing hormone level on the HCG injection day,progesterone level on the HCG injection day,the number of ovums in meiosis metaphase Ⅱ,the number of available embryos,clinical pregnancy rate,embryo implantation rate and abortion rate of patients between the two groups(P>0.05).The Gn usage time and the number of obtaining ovums of patients in the elder group were significantly lower than those in the younger group,while the rate of high-quality embryos was significantly higher than that in the younger group(P<0.05).Conclusion　HP-HMG ovulation induction is helpful to improve the high-quality embryos rate of elderly infertile patients with normal ovarian reserve and improve the pregnancy outcome of IVF-ET.

参考文献/References:

［1］　乔杰,杨蕊.高龄辅助生殖技术临床结局［J］.中国实用妇科与产科杂志,2017,33(1):64-67.
QIAO J,YANG R.Clinical outcomes of assisted reproductive technology in women at advanced maternal age［J］.CJPGO,2017,33(1):64-67.
［2］　马亚兰,张欣,李丹丹,等.卵巢功能储备正常者拮抗剂方案COH使用过程中添加高纯度人绝经促性腺激素对IVF-ET妊娠结局的影响［J］.吉林大学学报(医学版),2018,44(5):1036-1040.
MA Y L,ZHANG X,LI D D,et al.Influence of high-purity human menopausal gonadotrophin added in process of antagonist program COH in IVF-ET pregnancy outcomes in patients with normal ovarian function reserve［J］.J Jilin Univ (Med Ed),2018,44(5):1036-1040.
［3］　BISSONNETTE F,MINANO MASIP J,KADOCH I J,et al.Individualized ovarian stimulation for in vitro fertilization:a multicenter,open label,exploratory study with a mixed protocol of follitropin delta and highly purified human menopausal gonadotropin［J］.Fertil Steril,2021,115(4):991-1000.
［4］　孙青,黄国宁,孙海翔,等.胚胎实验室关键指标质控专家共识［J］.生殖医学杂志,2018,27(9):836-851.
SUN Q,HUANG G N,SUN H X,et al.CSRM consensus on key indicators for quality control in ivf laboratory［J］.J Reprod Med,2018,27(9):836-851.
［5］　中华医学会生殖医学分会.中国高龄不孕女性辅助生殖临床实践指南［J］.中国循证医学杂志,2019,19(3):253-270.
CHINESE SOCIETY OF REPRODUCTIVE MEDICINE.Chinese practice guideline on the assisted reproductive technology (ART) strategies for women with advanced age［J］.CJEBM,2019,19(3):253-270.
［6］　田东梅,李亨利,朱明辉,等.卵巢储备正常者COH不同阶段添加高纯度人绝经期促性腺激素对IVF-ET结局的影响［J］.生殖与避孕,2016,36(9):769-773.
TIAN D M,LI H L,ZHU M H,et al.Effects of highly purified human menopausal gonadotrophin(HP-HMG) supplementation on IVF-ET outcomes in patients with normal ovarian reserve during different period of controlled ovarian hyperstimulation［J］.Reprod Contracept,2016,36(9):769-773.
［7］　刘景瑜,王玢,孙海翔.PCOS患者体外受精周期r-FSH和HP-HMG促排卵临床结局的比较［J］.实用妇产科杂志,2014,30(4):291-294.
LIU J Y,WANG F,SUN H X.Clinical outcome following stimulation with recombinant FSH or highly purified HMG in PCOS patients undergoing IVF［J］．JPOG,2014,30(4):291-294.
［8］　ANDERSEN A N,DEVROEY P,ARCE J C.Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF:a randomized assessor-blind controlled trial［J］.Hum Reprod,2006,21(12):3217-3227.
［9］　HOMPES P G,BROEKMANS F J,HOOZEMANS D A,et al.Effectiveness of highly purified human menopausal gonadotropin vs.recombinant follicle-stimulating hormone in first-cycle in vitro fertilization-intracytoplasmic sperm injection patients［J］.Fertil Steril,2008,89(6):1685-1693.
［10］　SCHEFFER J B,SCHEFFER B B,DE CARVALHO R F,et al.Age as a predictor of embryo quality regardless of the quantitative ovarian response［J］.Int J Fertil Steril,2017,11(1):40-46.
［11］　BALASCH J,FABREGUES F.Is luteinizing hormone needed for optimal ovulation induction［J］.Curr Opin Obstet Gynecol,2002,14(3):265-274.
［12］　刘茜桐,田莉,马淳,等.长方案添加HMG时机对供精体外受精-胚胎移植结局的影响［J］.生殖医学杂志,2017,26(7):661-665.
LIU Q T,TIAN L,MA C,et al.Effect of timing of adding HMG in the long protocol on the outcome of IVF-ET with donor sperm［J］.J Reprod Med,2017,26(7):661-665.
［13］　WEISS G,SKURNICK J H,GOLDSMITH L T,et al.Menopause and hypothalamic-pituitary sensitivity to estrogen［J］.JAMA,2004,292(24):2991-2996.
［14］　徐茂青,金萱.卵泡液中LH、E2、P与女性年龄的相关性分析［J］.河北医学,2019,25(7):1122-1126.
XU M Q,JIN X.Correlation analysis between LH,E2 and P in follicular fluid and female age［J］.Hebei Med,2019,25(7):1122-1126.
［15］　MAHER J Y,SEGARS J.When is recombinant luteinizing hormone supplementation beneficial during ovarian stimulation［J］.Fertil Steril,2018,109(4):611-612.
［16］　ALVIGGI C,CONFORTI A,ESTEVES S C,et al.Recombinant luteinizing hormone supplementation in assisted reproductive technology:a systematic review［J］.Fertil Steril,2018,109(4):644-664.
［17］　RUVOLO G,BOSCO L,PANE A,et al.Lower apoptosis rate in human cumulus cells after administration of recombinant luteinizing hormone to women undergoing ovarian stimulation for in vitro fertilization procedures［J］.Fertil Steril,2007,87(3):542-546.
［18］　DAVISON S L,BELL R,DONATH S,et al.Androgen levels in adult females:changes with age,menopause,and oophorectomy［J］.J Clin Endocrinol Metab,2005,90(7):3847-3853.
［19］　BEN-AMI I,ARMON L,FREIMANN S,et al.EGF-like growth factors as LH mediators in the human corpus luteum［J］.Hum Reprod,2009,24(1):176-184.
［20］　WOLFENSON C,GROISMAN J,COUTO A S,et al.Batch-to-batch consistency of human-derived gonadotrophin preparations compared with recombinant preparations［J］.Reprod Biomed Online,2005,10(4):442-454.
［21］　BALASCH J,F A·BREGUES F,CASAMITJANA R,et al.A pharmacokinetic and endocrine comparison of recombinant follicle-stimulating hormone and human menopausal gonadotrophin in polycystic ovary syndrome［J］.Reprod Biomed Online，2003,6(3):296-301.
［22］　乔杰,马彩虹,刘嘉茵,等.辅助生殖促排卵药物治疗专家共识［J］.生殖与避孕,2015,35(4):211-223.
QIAO J,MA C H,LIU J Y,et al.A consensus of poor ovarian response［J］.Reprod Contracept,2015,35(4):211-223.

相似文献/References:

[1]李国芸,赵盂军,杨颍.内分泌功能障碍不孕89例疗效结果分析[J].新乡医学院学报,2001,18(06):430.
[2]徐明明.不明原因不孕症患者谷胱甘肽S-转移酶M1 基因遗传多态性[J].新乡医学院学报,2011,28(02):214.
[3]付蕊红.宫腔镜联合腹腔镜在女性不孕症诊断及治疗中的应用[J].新乡医学院学报,2014,31(11):937.[doi:10.7683/xxyxyxb.2014.11.021]

更新日期/Last Update: 2022-06-05